Lupin recalls blood pressure drug from US

Drug firm Lupin is recalling one batch of Losartan Potassium Tablets, used in treating high blood pressure, from the US market for exceeding permissible impurity level.  According to the US Food and Drug Administration (USFDA) in its enforcement report, Indian firm was recalling a batch of 34,368 bottlesas the drug did not meet specification for impurities at the nine-month stability station. The batch, which is being recalled, was due to expire in July next year. The company produces the drug at its Goa facility. The recall falls under the FDA's class II category which means that the use of the drug may cause temporary or medically reversible adverse health consequences, but unlikely to have serious adverse health consequences.crackcrack